COMMUNITY-ACQUIRED PNEUMONIA
Condition Identity
Community-Acquired Pneumonia
Infectious โ Lower respiratory tract infection
Typical vs Atypical
Acquired outside of hospital or healthcare settings
Epidemiology
Risk Factors
- Age >65 years
- Chronic lung disease (COPD, asthma, bronchiectasis)
- Smoking (active or former)
- Immunosuppression (HIV, chemotherapy, corticosteroids)
- Diabetes mellitus
- Chronic heart failure
- Chronic liver or renal disease
- Alcohol use disorder
- Recent viral upper respiratory tract infection
- Aspiration risk (dysphagia, reduced consciousness)
- Overcrowding and poor ventilation
- Malnutrition
Signs & Symptoms
- Fever (โฅ38ยฐC) or hypothermia (<35ยฐC)
- Tachypnoea (respiratory rate >20/min)
- Tachycardia (heart rate >100 bpm)
- Hypotension (systolic BP <90 mmHg)
- Reduced oxygen saturation (SpOโ <94% on room air)
- Dullness to percussion over affected lobe
- Bronchial breath sounds
- Coarse inspiratory crackles / crepitations
- Increased vocal resonance and tactile vocal fremitus
- Reduced chest expansion on affected side
- Pleural rub (if parapneumonic effusion)
- Central or peripheral cyanosis (severe cases)
- Use of accessory muscles of respiration
- Altered mental status / confusion (especially elderly โ CURB-65 criterion)
- Acute-onset productive cough with purulent or rusty sputum
- Fever with chills and rigors
- Pleuritic chest pain (sharp, worse on inspiration)
- Progressive dyspnoea and breathlessness
- General malaise and fatigue
- Myalgia and arthralgia
- Headache
- Anorexia and nausea
- Diaphoresis (night sweats)
- Haemoptysis (occasional, especially in Klebsiella or severe infection)
Complications
DOWNSTREAM CLINICAL COMPLICATIONS & SEQUELAE
- Parapneumonic effusion
- Empyema
- Lung abscess
- Sepsis and septic shock
- Acute respiratory distress syndrome (ARDS)
- Respiratory failure
- Multi-organ dysfunction syndrome
- Metastatic infection (meningitis, endocarditis)
Diagnostic Criteria
DIAGNOSTIC RED FLAGS & EMERGENCY RULE-OUTS
- CURB-65 score โฅ3
- Hypoxia (SpOโ <92%)
- Bilateral or multilobar infiltrates
- Septic shock (SBP <90 mmHg)
- Inability to maintain oral intake
- Failure to improve after 48โ72 hours of appropriate antibiotics
- New-onset cough with or without sputum
- Fever โฅ38ยฐC or hypothermia <35ยฐC
- Pleuritic chest pain
- Dyspnoea
- Focal chest signs on auscultation (crackles, bronchial breathing)
- Tachycardia >100 bpm
- Tachypnoea >20 breaths/min
- Confusion (new onset)
| Condition | Distinguishing Features | Recommended Workup |
|---|---|---|
| Acute bronchitis โ | โ | โ |
| Acute exacerbation of COPD โ | โ | โ |
| Pulmonary embolism โ | โ | โ |
| Lung cancer โ | โ | โ |
| Tuberculosis โ | โ | โ |
| Heart failure with pulmonary oedema | โ | โ |
| COVID-19 pneumonia | โ | โ |
| Hypersensitivity pneumonitis | โ | โ |
Investigations
Bedside Tests
- Pulse oximetry
- Temperature
- Blood pressure and heart rate
- Respiratory rate
- Sputum Gram stain and culture
- Urinary antigen testing (Legionella, Pneumococcus)
First-Line Diagnostic Tests
- Chest X-ray (PA and lateral)
- Full blood count (FBC)
- Urea and electrolytes
- C-reactive protein (CRP)
- Blood cultures (ร2 sets before antibiotics)
- Arterial blood gas (if SpOโ <94% or severe disease)
Confirmatory & Specialized Tests
- CT thorax (if diagnostic uncertainty)
- Bronchoscopy with BAL (if immunocompromised or non-resolving)
- Procalcitonin (to guide antibiotic duration)
- Pleural fluid analysis (if effusion present โ pH, protein, LDH, glucose, culture)
Continuous & Serial Monitoring
- Repeat CRP at 48โ72 hours
- Repeat chest X-ray at 6 weeks (to confirm resolution and exclude underlying malignancy)
- Blood cultures if not improving
Nonpharmacological Management
- Supportive oxygen therapy to maintain SpOโ 94โ98% (88โ92% if at risk of hypercapnia)
- Adequate oral or IV fluid hydration
- Rest and avoidance of strenuous activity
- Chest physiotherapy and incentive spirometry
- Smoking cessation counselling
- Nutritional support if malnourished
- VTE prophylaxis in hospitalised patients
Monitoring
- Defervescence within 48โ72 hours
- Improvement in cough and dyspnoea
- Normalising white cell count and CRP
- Ability to take oral medications and fluids
- CRP at 48โ72 hours (should fall by โฅ50%)
- Repeat blood cultures if persistent fever
- Procalcitonin to guide antibiotic cessation
- Clinical review at 48โ72 hours if outpatient
- Consider step-down from IV to oral antibiotics when: afebrile >24h, improving clinically, tolerating oral intake
- Follow-up chest X-ray at 6 weeks (mandatory for smokers >50 years to exclude underlying malignancy)
- No clinical improvement after 48โ72 hours
- Worsening hypoxia or haemodynamic instability
- Development of complications (effusion, empyema, abscess)
- Rising inflammatory markers
- Fever: 2โ3 days
- Cough: may persist 4โ6 weeks
- Chest X-ray: may take 6โ12 weeks to fully resolve
- Fatigue: may persist for several weeks
Prevention
- Pneumococcal vaccine (PCV13 and/or PPSV23) โ recommended for all adults โฅ65 years and high-risk groups
- Annual influenza vaccination
- COVID-19 vaccination
- Optimise management of chronic diseases (COPD, diabetes, heart failure)
- Aspiration precautions in high-risk patients
- Avoid unnecessary use of PPIs (associated with increased pneumonia risk)
- Smoking cessation
- Limit alcohol consumption
- Good hand hygiene
- Adequate nutrition and physical activity
- Complete the full antibiotic course even if feeling better
- Return if symptoms worsen or fail to improve within 48โ72 hours
- Importance of follow-up chest X-ray at 6 weeks
- When to seek emergency care (severe breathlessness, chest pain, confusion)
EMERGENCY RETURN PRECAUTIONS
- Worsening breathlessness or chest pain
- Persistent fever >72 hours despite antibiotics
- Confusion or drowsiness
- Inability to keep fluids down
- Coughing up blood
Prognosis
Prognosis depends on severity and comorbidities. Low-severity CAP (CURB-65 0โ1) has mortality <3%. Moderate-severity (CURB-65 2) has mortality 9โ13%. Severe CAP requiring ICU admission carries mortality up to 50%. Most patients with mild disease recover fully within 1โ3 weeks, although cough and fatigue may persist for 4โ6 weeks. Chest X-ray abnormalities may take up to 12 weeks to resolve. Elderly and immunocompromised patients have higher rates of complications and slower recovery.
Referral Criteria
ICU & EMERGENCY RESUSCITATION INDICATIONS
- Septic shock (requiring vasopressors)
- Respiratory failure (requiring mechanical ventilation)
- Multiorgan dysfunction
- Rapidly progressive multilobar disease
HOSPITAL ADMISSION INDICATIONS
- CURB-65 score โฅ2
- Hypoxia (SpOโ <92%)
- Inability to maintain oral intake
- Significant comorbidities with acute deterioration
- Social factors (unable to care for self at home)
- Recurrent pneumonia (โฅ2 episodes in 1 year or โฅ3 ever)
- Immunocompromised patients
- Diagnostic uncertainty
All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.